|
References
Ernst, E. "Chelation Therapy for Peripheral Arterial Occlusive
Disease: A Systemic Review." Review. Circulation.
1997. Volume 96 (3), 1031-1033.
Elihu, N., et al. "Chelation Therapy in Cardiovascular Disease:
Ethylenediaminetetraacetic Acid, Deferoxamine, Dexrazoxane." Journal
Clinical Pharmacology. 1998. Volume 38, 101-105.
Gundling, K. "Complementary and alternative medicine in
cardiovascular disease: what is the evidence that it works." Western
Journal of Medicine. 1999. Volume171, 193.
Lewin, MR. "Chelation Therapy for Cardiovascular
Disease." Review. Texas Heart Institute Journal.
1997. Volume 24 (2), 81-89.
New ReferencesKnudtson ML, "Chelation therapy for
ischemic heart disease: a randomized controlled trial". JAMA. 2002 Jan
23-30;287(4):481-6.
Villarruz MV, Dans A, Tan F, "Chelation therapy for
atherosclerotic cardiovascular disease (Review)" The Cochrane Database of
Systematic Reviews, 2006.
_ Chelation Therapy. American Cancer Society.
www.cancer.org/docroot/ETO/content/ETO_5_3X_Chelation_Therapy.asp 2005.
_Questions and Answers About Chelation Therapy. American Heart Association.
http://www.americanheart.org/presenter.jhtml?identifier=3000843. 2006.
_American College of Cardiology Position Statement: Chelation Therapy.
http://www.acc.org/clinical/position/72540.htm 1999.
Saul G. Chelation Therapy: Unproven Claims and Unsound Theories.
Quackwatch. 2002. |
